Issue 2/2020
Content (14 Articles)
The Diagnostic Dilemma of GATA3 Immunohistochemistry in Pheochromocytoma and Paraganglioma
Noriko Kimura, Kiyoto Shiga, Kenichi Kaneko, Chiho Sugisawa, Takayuki Katabami, Mitsuhide Naruse
Immunohistochemical Profile and 47-Gene Next-Generation Sequencing (NGS) Solid Tumor Panel Analysis of a Series of 13 Strumal Carcinoids
S. Theurer, M. Ingenwerth, T. Herold, K. Herrmann, K. W. Schmid
Alternative Lengthening of Telomeres and Differential Expression of Endocrine Transcription Factors Distinguish Metastatic and Non-metastatic Insulinomas
Wenzel M. Hackeng, Willemien Schelhaas, Folkert H. M. Morsink, Charlotte M. Heidsma, Susanne van Eeden, Gerlof D. Valk, Menno R. Vriens, Christopher M. Heaphy, Els J. M. Nieveen van Dijkum, G. Johan A. Offerhaus, Koen M. A. Dreijerink, Lodewijk A. A. Brosens
Histopathological and Immunophenotypic Changes of Pancreatic Neuroendocrine Tumors after Neoadjuvant Peptide Receptor Radionuclide Therapy (PRRT)
Marco Schiavo Lena, Stefano Partelli, Paola Castelli, Valentina Andreasi, Chanel Elisha Smart, Eleonora Pisa, Mirco Bartolomei, Emilio Bertani, Giuseppe Zamboni, Massimo Falconi, Claudio Doglioni
Histopathologic Assessment of Capsular Invasion in Follicular Thyroid Neoplasms—an Observer Variation Study
Yun Zhu, Yaqiong Li, Chan Kwon Jung, Dong Eun Song, Jen-Fan Hang, Zhiyan Liu, Deepali Jain, Chiung-Ru Lai, Mitsuyoshi Hirokawa, Kennichi Kakudo, Andrey Bychkov
Thyroid Tumor Capsular Invasion: the Bottom Line or Much Ado About Nothing?
Ozgur Mete, Sylvia L. Asa
Did Introducing a New Category of Thyroid Tumors (Non-invasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features) Decrease the Risk of Malignancy for the Diagnostic Categories in the Bethesda System for Reporting Thyroid Cytopathology?
Janusz Kopczyński, Agnieszka Suligowska, Kornelia Niemyska, Iwona Pałyga, Agnieszka Walczyk, Danuta Gąsior-Perczak, Artur Kowalik, Kinga Hińcza, Ryszard Mężyk, Stanisław Góźdź, Aldona Kowalska
Utility of GATA-3 Expression in the Analysis of Pituitary Neuroendocrine Tumour (PitNET) Transcription Factors
John Turchini, Loretta Sioson, Adele Clarkson, Amy Sheen, Anthony J. Gill
Lipoadenoma of the Parathyroid Gland: Characterization of an Institutional Series Spanning 28 Years
C. Christofer Juhlin, Henrik Falhammar, Jan Zedenius, Inga-Lena Nilsson, Anders Höög
Frequency and Role of CDKN2A Deletion in High-Risk Pituitary Neuroendocrine Tumors
Müjdat Kara, Fatma Tokat, M. Necmettin Pamir, Ayça Ersen Danyeli
Practice Paradigms Before and After Introduction of the Diagnosis-Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP): an Institutional Experience
Levon Katsakhyan, Sharon Song, Marcos Lepe, Hadi Shojaei, Kathleen T. Montone, Virginia A. LiVolsi, Zubair W. Baloch
Homogeneous MMR Deficiency Throughout the Entire Tumor Mass Occurs in a Subset of Colorectal Neuroendocrine Carcinomas
Christoph Fraune, Ronald Simon, Claudia Hube-Magg, Georgia Makrypidi-Fraune, Martina Kluth, Franziska Büscheck, Tania Amin, Fabrice Viol, Wilfrid Fehrle, David Dum, Doris Höflmayer, Eike Burandt, Till Sebastian Clauditz, Daniel Perez, Jakob Izbicki, Waldemar Wilczak, Guido Sauter, Stefan Steurer, Jörg Schrader
Images in Endocrine Pathology: High-Grade Intrathyroidal Parathyroid Carcinoma with Crooke’s Hyalinization
Mingfei Yan, Kara L. Roncin, Scott Wilhelm, Jay K. Wasman, Sylvia L. Asa